Form 8-K - Current report:
SEC Accession No. 0001558370-24-013565
Filing Date
2024-10-24
Accepted
2024-10-24 08:05:19
Documents
15
Period of Report
2024-10-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrns-20241024x8k.htm   iXBRL 8-K 44646
2 EX-99.1 mrns-20241024xex99d1.htm EX-99.1 33673
3 GRAPHIC mrns-20241024xex99d1001.jpg GRAPHIC 8643
  Complete submission text file 0001558370-24-013565.txt   222185

Data Files

Seq Description Document Type Size
4 EX-101.SCH mrns-20241024.xsd EX-101.SCH 3257
5 EX-101.LAB mrns-20241024_lab.xml EX-101.LAB 16595
6 EX-101.PRE mrns-20241024_pre.xml EX-101.PRE 10717
17 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20241024x8k_htm.xml XML 5113
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 241390784
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)